Hongzhou Zuo
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Association of Statin use with Parkinson's Disease Progression in a Prospective Cohort Study and Multi-omics Analyses.
Journal: Journal of molecular neuroscience : MN
Published: November 24, 2025
Microbiota-Driven microglia reprogramming reverses depressive-like behaviors through Peripheral-to-Central immune crosstalk.
Journal: Molecular psychiatry
Published: September 24, 2025
Cerebral microbleeds aggravate severity of motor function, cognitive and emotional status in Parkinson's disease.
Journal: Acta neurologica Belgica
Published: February 20, 2025
Chronic stress in mice: how gut bacteria influence gene activity in key brain neurons.
Journal: Translational psychiatry
Published: February 15, 2025
Triglyceride-glucose index predicts cognitive decline and striatal dopamine deficiency in Parkinson disease in two cohorts.
Journal: NPJ Parkinson's disease
Published: October 26, 2024
Effects of Liuzijue Qigong on respiratory function among patients with Parkinson's disease: a randomized clinical trial.
Journal: BMC complementary medicine and therapies
Published: July 09, 2024
Deep cervical lymph nodes in Parkinson's disease and atypical Parkinson's disease: A potential ultrasound biomarker for differential diagnosis.
Journal: Journal of central nervous system disease
Published: November 25, 2023
Assessment of bidirectional relationships between multiple sclerosis and epilepsy: A two-sample Mendelian randomization study.
Journal: Multiple sclerosis and related disorders
Published: September 30, 2023
Altered connectivity in the cognitive control-related prefrontal cortex in Parkinson's disease with rapid eye movement sleep behavior disorder.
Journal: Brain imaging and behavior
Published: August 30, 2023
Cerebral small vessel disease increases risk for epilepsy: a Mendelian randomization study.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: August 29, 2023
Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer's disease-associated biomarkers alterations among de novo Parkinson's disease patients: a prospective cohort study.
Journal: Journal of neuroinflammation
Published: April 23, 2023
Last Updated: 09/26/2026